PRELUDE CAPITAL MANAGEMENT, LLC - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is and the CUSIP is 012423AB5. A total of 23 filers reported holding ALBANY MOLECULAR RESH INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q2 2016$566,000
-46.2%
550,000
-42.1%
0.08%
-46.3%
Q1 2016$1,053,000
+56.0%
950,000
+90.0%
0.15%
+40.0%
Q4 2015$675,000500,0000.10%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q2 2016
NameSharesValueWeighting ↓
ALTEGRIS ADVISORS, L.L.C. 1,750,000$1,930,0008.43%
Context Capital Management, LLC 5,625,000$6,240,0007.76%
Mohican Financial Management, LLC 3,700,000$4,082,0004.15%
Opera Trading Capital 7,000,000$7,786,0002.04%
BASSO CAPITAL MANAGEMENT, L.P. 4,800,000$5,328,0000.89%
Verition Fund Management LLC 4,500,000$4,987,0000.81%
CSS LLC/IL 9,700,000$10,779,0000.66%
WOLVERINE ASSET MANAGEMENT LLC 15,000,000$16,664,0000.47%
SSI INVESTMENT MANAGEMENT LLC 3,500,000$3,861,0000.40%
PRELUDE CAPITAL MANAGEMENT, LLC 950,000$1,053,0000.15%
View complete list of ALBANY MOLECULAR RESH INC shareholders